2018
DOI: 10.1093/annonc/mdy428.013
|View full text |Cite
|
Sign up to set email alerts
|

Molecular tumor board (MTB): Development of clinical pathways for precision medicine. Experiences of center for breast cancer at national cancer center, Korea

Abstract: Background: The aim of the current study was to investigate the role of Circular RNA(circRNA) circASS1 in breast cancer(BC) cells, and this may be a novel therapy and a potential diagnostic biomarker or targeted treatment of BC. Methods: We analyzed the expression profile of human circRNAs in two BC cell lines: MCF-7, MDA-MB-231 by the circRNAs microarray, and we found the dysregulated circRNA: circASS1. Then the expression of circASS1 in breast cancer cells were identified. Next, measure of the abilities of i… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles